Back
Hepion Pharmaceuticals Vs. Affirm Holdings Industry Stock Comparison
Sell
23
HEPA
Hepion Pharmaceuticals
Last Price:
0.65
Seasonality Move:
10.8%
Buy
53
AFRM
Affirm Holdings
Last Price:
54.82
Seasonality Move:
1.82%
Sell
23
Hepion Pharmaceuticals (HEPA)
is a Sell
Is Hepion Pharmaceuticals a Buy, Sell or Hold?
- The current Hepion Pharmaceuticals [HEPA] share price is $0.63. The Score for HEPA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- HEPA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Affirm Holdings (AFRM)
is a Buy
Is Affirm Holdings a Buy, Sell or Hold?
- The current Affirm Holdings [AFRM] share price is $57.56. The Score for AFRM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- AFRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HEPA Stock Price Chart
What is Hepion Pharmaceuticals's stock price today?
-
The Hepion Pharmaceuticals share price today is $0.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HEPA is experiencing selling pressure, which indicates risk of future bearish movement.
AFRM Stock Price Chart
What is Affirm Holdings's stock price today?
-
The Affirm Holdings share price today is $57.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AFRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
HEPA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.12 | Sell |
| Chaikin Money Flow: | -30750 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.72) | Sell |
| Bollinger Bands (100): | (0.61 - 0.91) | Sell |
AFRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 71.38 | Buy |
| Chaikin Money Flow: | 13820195 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.35 - 50.03) | Buy |
| Bollinger Bands (100): | (28.43 - 44.53) | Buy |
HEPA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.64 | Sell |
| 20-day SMA: | 0.67 | Sell |
| 50-day SMA: | 0.67 | Sell |
| 200-day SMA: | 1.28 | Sell |
| 8-day EMA: | 0.64 | Sell |
| 20-day EMA: | 0.65 | Sell |
| 50-day EMA: | 0.69 | Sell |
| 200-day EMA: | 1.72 | Sell |
AFRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.12 | Buy |
| 20-day SMA: | 45.98 | Buy |
| 50-day SMA: | 43.52 | Buy |
| 200-day SMA: | 35.74 | Buy |
| 8-day EMA: | 50.67 | Buy |
| 20-day EMA: | 47.02 | Buy |
| 50-day EMA: | 43.01 | Buy |
| 200-day EMA: | 35.89 | Buy |
Hepion Pharmaceuticals Earnings Growth & HEPA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.00 per share.
Affirm Holdings Earnings Growth & AFRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $1.43 per share.
Hepion Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Affirm Holdings Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||